The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress

Toxicology

Volumn 123, Issue 1-2, 1997, Pages 33-40

  Hultberg, Björn ^a   Andersson, Anders ^a   Isaksson, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Copper ions; Cysteine; Endothelial cell culture; Glutathione; HeLa cell culture; Homocysteine

Indexed keywords

COPPER ION; CYSTEINE; GLUTATHIONE; HOMOCYSTEINE;

ARTICLE; ATHEROGENESIS; CELL CULTURE; CELL DAMAGE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

CATIONS, DIVALENT; CELL DIVISION; CELL LINE, TRANSFORMED; COPPER; CYSTEINE; ENDOTHELIUM; GLUTATHIONE; HELA CELLS; HOMOCYSTEINE; HUMANS; OXIDATIVE STRESS;

EID: 0030801910     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00105-4     Document Type: Article

References (33)

1. Andersson, A., Isaksson, A., Brattström, L., Hultberg, B., 1993. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin. Chem. 39, 1590-1597.
2. Andersson, A., Lindgren, A., Hultberg, B., 1995. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin. Chem. 41, 361-366.
3. Berman, R.S., Martin, W., 1993. Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. Br. J. Pharmacol. 108, 920-926.
4. Bethin, K.E., Cimato, T.R., Ettinger, M.J., 1995. Copper binding to mouse liver S-adenosylhomocysteine hydrolase and the effects of copper on its levels. J. Biol. Chem. 270, 20703-20711.
5. Blom, H.J., Kleinveld, H.A., Boers, G.H.J., Demacker, P.N.M., Hak-Lemmers, H.L.M., Te Poele-Pothoff, M.T.W.B., Tribels, J.M.F., 1995. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinemia. Eur. J. Clin. Invest. 25, 149-154.
6. Boers, G.H.J., Smals, A.G.H., Trijbels, F.J.M., Fowler, B., Bakkeren, J.A.J.M., Schoonderwaldt, H.C., Kleijer, W.J., Kloppenborg, P.W.C., 1985. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313, 709-715.
7. Boushey, C.J., Beresford, S.A.A., Omenn, G.S., Motulsky, A.G., 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274, 1049-1056.
8. Brattström, L., Hardebo, J., Hultberg, B., 1984. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 15, 1012-1016.
9. Cartana, J., Romeu, A., Arola, L., 1992. Effect of copper, cadmium and nickel on liver and kidney glutathione redox cycle of rats. Comp. Biochem. Physiol. 101C, 209-213.
10. Clarke, R., Leslie, D., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., Graham, I., 1991. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155.
11. Clarke, R., Naughten, E., Calahane, S., Sullivan, K.O., Mathias, P., McCall, T., Graham, I., 1992. The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia. Ir. J. Med. Sci. 161, 561.
12. DeGroot, P.G., Willems, C., Boers, G.H.J., Gonsalves, M.D., Van Aken, W.G., Van Mourik, J.A., 1983. Endothelial cell dysfunction in homocystinuria. Eur. J. Clin. Invest. 13, 405-410.
13. Dudman, N.P.B., Wilcken, D.E.L., Stocker, R., 1993. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis. Arterioscler. Thromb. 13, 512-516.
14. Freedman, J.H., Ciriolo, M.R., Peisach, J., 1989. The role of glutathione in copper metabolism and toxicity. J. Biol. Chem. 264, 5598-5605.
15. Fryer, R.H., Wilson, B.D., Gubler, D.B., Fitzgerald, L.A., Rodgers, G.M., 1993. Homocysteine, a risk factor for premature vascular disease, induces tissue factor activity in endothelial cells. Arterioscler. Thromb. 13, 1327-1333.
16. Hajjar, K.A., 1993. Homocysteine-induced modulation of tissue factor to its endothelial cell membrane receptor. J. Clin. Invest. 91, 2873-2880.
17. Hultberg, B., Andersson, A., Isaksson, A., 1995. Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937). Biochim. Biophys. Acta 1269, 6-12.
18. Hultberg, B., Andersson, A., Isaksson, A., 1997. Copper ions differ from other metal ions in their effects on the concentration and redox status of thiols in HeLa cell cultures. Toxicology 117, 89-97.
19. Jocelyn, P.C., 1972. Chemical reactions of thiols. In: Biochemistry of the SH Group. Academic Press, London, pp. 116-136.
20. Lentz, S.R., Sadler, J.E., 1991. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest. 88, 1906-1914.
21. Lentz, S.R., Sadler, J.E., 1993. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81, 683-689.
22. Loscalzo, J., 1996. The oxidant stress of hyperhomocysteinemia. J. Clin. Invest. 98, 5-7.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Malinow, M.R., Kang, S.S., Taylor, L.M., Wong, P.W.K., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., Upson, B., 1989. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation 79, 1180-1189.
25. Malinow, M.R., 1995. Plasma homocysteine and arterial occlusive diseases: a mini-review. Clin. Chem. 41, 173-176.
26. Mansoor, M.A., Bergmark, C., Svardal, A.M., Lonning, P.E., Ueland, P.M., 1995. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset perpheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 15, 232-240.
27. Meister, A., 1988. Gluthatione metabolism and its selective modification. J. Biol. Chem. 263, 17205-17208.
28. Mudd, S.H., Levy, H.L., Skouby F., 1989. Disorders of transsulfuration. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic Basis of Inherited Disease, 6th ed. McGraw-Hill, New York, pp. 693-734.
29. Nishinaga, M., Ozawa, T., Shimada, K., 1993. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J. Clin. Invest. 77, 1381-1386.
30. Rodgers, G.M., Kane, W.H., 1986. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Invest. 77, 1909-1916.
31. Stampfer, M.J., Malinow, M.R., Willet, W.C., Newcomer, L.M., Upson, B., Ullman, D., Tishler, P.V., Henneken, C.H., 1992. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J. Am. Med. Assoc. 268, 877-881.
32. Starkebaum, G., Harlan, J.M., 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77, 1370-1376.
33. Steinebach, O.M., Wolterbeek, H.T., 1994. Effects of copper on rat hepatoma HTC cells and primary cultured rat hepatocytes. J. Inorg. Biochem. 53, 27-48.